Product details Supply Impact Dates Further Details
MYTOLAC lanreotide (as acetate) 60 mg

AUST R: 371881

Active Ingredients: lanreotide acetate

Dosage From: Injection, solution
From: 29 Nov 2024

To: 28 Feb 2026
Shortage Status: Current

Availability: Unavailable

Reason: Transport / Logistic issues / Storage capacity issues
MYTOLAC lanreotide (as acetate) 120 mg

AUST R: 371879

Active Ingredients: lanreotide acetate

Dosage From: Injection, solution
From: 20 Jun 2025

To: 12 Aug 2025
Shortage Status: Resolved

Availability: Available

Reason: Manufacturing
MYTOLAC lanreotide (as acetate) 90 mg

AUST R: 371880

Active Ingredients: lanreotide acetate

Dosage From: Injection, solution
From: 01 Jan 2026

To: 31 Jan 2026
Shortage Status: Anticipated

Availability: Available

Reason: Manufacturing